Advertisement
BriaCell Therapeutics Cor... (BCTXZ)
NASDAQ: BCTXZ
· Real-Time Price · USD
1.28
0.02 (1.19%)
At close: Apr 29, 2025, 10:54 AM
1.19% (1D)
| Bid | 1.01 |
| Market Cap | 4.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.55 |
| Volume | 3,684 |
| Avg. Volume (20D) | 93,494.5 |
| Open | 1.29 |
| Previous Close | 1.26 |
| Day's Range | 1.28 - 1.29 |
| 52-Week Range | 1.28 - 1.29 |
| Beta | 1.71 |
About BCTXZ
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx,...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 25, 2025
Employees 16
Stock Exchange NASDAQ
Ticker Symbol BCTXZ
Website https://www.briacell.com